Twin Cities med-tech company NxThera to be sold to Boston Scientific in $400M deal
March 21, 2018 at 12:23 PM EDT
NxThera also will spin out a yet-to-be-named startup that will target the prostate cancer market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|